Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Biochem basis of human disease > cancer and angiogenesis > Flashcards

cancer and angiogenesis Flashcards

1
Q

what are the 5 main forms of cancer contributing to world wide mortality

A 
lung
stomach
liver
colorectal
breast
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

in normal tissues you have a balance of rate of growth and rate of death. in cancer this is …..

A

disrupted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is a neoplasm

A

abnormal mass of tissue, growth of which exceeds and is uncoordinated with normal tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is a tumour

A

non-specific term meaning lump or swelling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is cancer

A

any malignant neoplasm or tumour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what does metastasis mean

A

discontinuous spread of malignant neoplasm to distant sites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what happens in neoplasia at the cellular level (3)

A

excessive cellular proliferation
uncoordinated growth
tissue infiltration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what happens in neoplasia at the molecular level (2)

A

disorder of growth regulatory genes

develops in a multistep fashion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

there is an estimate of how many driver mutations in key genes that are required for cancer

A

5-15

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what does p53 do

A

stops cell cycle to enable repair to occur. if repair doesnt happen it trigger apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is Rb and what does it do

A

retinoblastoma protein - stops the cell cycle

frequently it is absent or mutated in cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are proto-oncogenes

A

normal genes whose protein product promotes growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

a proto-oncogene is turned into an oncogene as a consequence of what (3)

A

mutation
chromosomal rearrangement
gene amplification

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is a transcription factor that is amplified around 1000 fold in many cancers

A

Myc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

point mutation at glycine 12 to any other amino acid locks what in the hyperactive permanently on state

A

Ras

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are tumour supressor genes

A

genes that encode proteins that discourage cell growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

there are 2 main pathways of apoptosis. these are:

A

intrinsic and extrinsic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what are the key steps to the intrinsic apoptosis pathway

A

recognition of damage by p53
upregulation of BAX (pro-apoptotic protein - usually inhibited by Bcl-2)
cytochrome C released from mitochondria and binds to APAP1 with caspase 9 in centre

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what do cancer cells upregulate in regard to the intrinsic apoptotic pathways

A

Bcl-2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

how does the extrinsic pathway of apoptosis occur

A

signals from outside bind to the death receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what do cancer cells mutate in regard to the extrinsic apoptotic pathway

A

the death receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what is the original two hit hypothesis of cancer

A

1st event - initiation

2nd event - promotion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

the alternative theory is that multiple hits occur and that there is a lag time between exposure (1st hit) and deelopment of clinically apparent cancer

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

what are the hallmarks of cancer (6)

A 
sustaining proliferative signalling
evading growth supressors
activation invasion and metastasis
enabling replicative immortality
inducing angiogenesis
resisting cell death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

what are the emerging hallmarks of cancer

A

deregulating cellular energetics - use glycolysis instead of oxidative phosphorylation
avoiding immune destruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

what are the enabling characteristics that allow all the hallmarks of cancer to occur

A

genome instability and mutation

tumour promoting inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

what is angiogenesis

A

the development of new blood vessels from the existing vasculature

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

angiogenesis is found in over 50 diseases including (3)

A

chronic inflammatory disease
vascular malformations
cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

which blood vessels are more likely to respond to angiogenesis signals

A

capillaries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

what are endothelial cells naturally held in check by balance of

A

pro-angiogeneic promoters (VEGF, PDGF, FGF) and anti-angiogenic inhibitors (thrombospondin 1)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

why cant tumours grow beyond 1-2mm cubed without a blood supply

A

due to diffusion limits of oxygen and nutrients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

as tumours grow they alter their microenvironment this includes (4)

A

pH
concentration of nutrients
increase in interstitial pressure
decrease in oxygen tension (hypoxia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

cells respond to the changes in tumour microenvironment by generating what

A

angiogenic molecules eg VEGF to extend blood vasculature to relieve pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

why is tumour angiogenesis such a problem

A
  • it supports growth of a tumour by providing nutrients and gas exchange
  • it allows tumours to invade their surroundings
  • it promotes metastasis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

what are the steps in tumour induced spouting angiogenesis

A
  1. release of angiogenic factors
  2. activation of endothelial cells
  3. matrix degradation
  4. release of cell-matrix contacts
  5. endothelial cell migration and invasion
  6. endothelial cell proliferation
  7. lumen formation
  8. capillary formation
  9. vascular stabilisation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

the first step of tumour induced sprouting angiogenesis is the release of angiogenic factors this is in response to certain conditions such as

A

stress
hypoxia
hormones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

hypoxia results in the translocation of HIF-1alpha and HIF-1beta to nucleus where they act as transcription factor for genes containing a hypoxia response element in their promoters. what is a prime example of one of these genes

A

VEGF

38
Q

what is VEGF

A

vascular endothelial growth factor

most abundantly expressed angiogenic factor

39
Q

there are various isoforms of VEGF, which is the most common

A

VEGF165

40
Q

VEGF bind to VEGFR2 on surface of endothelial cells. which signalling pathway is activated

A

Ras and MAPK pathway via Grb2

41
Q

activation of the Ras MAPK pathway by VEGF leads to what

A

matrix breakdown, proliferation, migration, permeability and tube formation

42
Q

in the 3rd step of tumour induced sprouting angiogenesis the matrix is degraded. what is commonly upregulated in this step

A

MMPs and TIMPs

43
Q

what are MMPs

A

matrix metalloproteins - cleave ECM components. regulate EC attachment, migration and proliferation

44
Q

what are TIMPs

A

tissue inhibitors of MMPs

block angiogenic response

45
Q

why is a balance required between MMPs and TIMPs in angiogenesis

A

when the level of proteolysis is too high, angiogenesis is inhibited

46
Q

step 4 of the tumour induced sprouting angiogenesis requires that endothelial cells change their what

A

integrins

47
Q

tumour cells down regulate and upregulate which integrins

A

downregulate alpha2beta1

upregulate alpha5beta1

48
Q

what do integrins mediate

A

cell migration and cell adhesion to a variety of matrix proteins

49
Q

what does binding growth factors to endothelial cells cause

A

Down regulation of integrins for basement membrane alpha2beta1
Up regulation of integrins for extracellular matrix alpha5beta1

50
Q

in step 5 of tumour induced sprouting angiogenesis, MMPs degrade the basement membrane allowing cells to invade through it. endothelial cells migrate into area that requireds new vessels through a conc gradient of what

A

chemoattractants including VEGF

51
Q

in step 6 of tumour induced sprouting angiogenesis endothelial cells enter the cell cycle to replicate and provide enough new cells for the new vessels to grow. which cell leads the way

A

tip cell

52
Q

lumen fromation depends on whether its what

A

single cellular strand or double cellular strand

53
Q

lumen formation of single cellular strand and double cellular strand both start with what

A

pinocytosis - pinching of the membrane

54
Q

what are the steps to lumen formation in single cellular strand

A
  • pinocytosis
  • vesicles form
  • vesicles fuse
  • vesicles line up along central line
  • get vacuole fusion
  • exocytosis and luminal expansion
55
Q

what are the steps to lumen formation in double cellular strand

A
  • pinocytosis
  • repolarisation of cell
  • vesicular fusion
  • vacuolar fusion
  • luminal expansion
56
Q

in step 8 of tumour induced sprouting angiogenesis capillaries are formed. endothelial cells differentiate. vacuoles join to form lumen and anastamosis occurs. what does this mean

A

joining of many capillaries

57
Q

in the final step of tumour induced sprouting angiogenesis is vascular stabilisation. endothelial cells lay down basement membrane followed by the recruitment of what

A

pericytes and smooth muscle cells

58
Q

how do tumour vessels differ from normal vessels

A
  • increased vessel number per area
  • more proliferating endothelial cells
  • decreased endothelial cell-cell adhesion (easier route for metastasis)
  • leaky vessels
  • decreased vessel stability
  • loss of close association of basement membrane with endothelial cells
59
Q

why is angiogenesis important

A
  • results in increased oxygen and nutrients for tumour cell

- by increasing the number of vessels in a tumour, more cancer cells can escape

60
Q

what is sprouting angiogenesis

A

production of new vessels from existing vasculature (cancer cells being stressed upregulating HIf then VEGF, VEGF bind to receptor on endothelial cells, endothelial cells being activated by VEGF signalling pathway, producing MMPs to breakdown basemen membrane, EC changing integrin expression, migrating and then proliferation and then forming the lumen and joining up)

61
Q

delivery of blood borne agents to tumour cell targets in solid tumours has proven difficult due to:

A

abnormal blood flow
lack of lymph damage
high interstitial pressure (hard for things to move in)
poor access to majority of tumour mass

62
Q

tumour cells are inherently unstable and quickly become resistant to therapy T/F

A

T

63
Q

occlusion of a single vessel has the potential for killing many tumour cells T/F

A

T

64
Q

when targetting tumour blood vessels resistance is less likely to develop - why

A

endothelial cells are not malignant

65
Q

what makes a good drug

A 
specificity
preferable oral administation
hydrophilic
good pharmokinetics
not toxic
66
Q

how do you test a new drug

A

relevant in vitro studies
pre clinical in vivo studies
clinical trials

67
Q

what are the stages of clinical trials

A

o Phase one – small group (last attempt of treatment). Looking at side effects and dosage, how best to give the drug (pill or injection)
o Phase two – effectiveness of drug and the safety
o Phase three – randomised controlled trials 300+ people

68
Q

what are the potential study end points in phase 3 trials

A 
LOW:
response rate
progression free survival
overall survival
quality of life
cost effectiveness
69
Q

what is • response evaluation criteria in solid tumours (RECIST)

A

a set of published rules that define tumour response rate

70
Q

what are the advantages and disadvantages of using response rate

A

adv - early primary endpoint
dis - poor correlation with overall survival
subjective measurement

71
Q

what are the advantages and disadvantages of using progression free survival

A

adv - early primary endpoint
dis - poor correlation with overall survival
subjective measurement

72
Q

what are the advantages and disadvantages of using overall survival

A

adv - direct measurement of quantity of life
objective - easy to measure

dis - late primary endpoint
potential confounding effects of post progression therapy

73
Q

what is bevacizumab

A

humanised monoclonal antibody

blocks binding of VEGF to its main receptors

74
Q

the clinical trials do not show the same promising efficacy that in vivo studies show but some stabilisation of disease has been reported T/F

A

T

75
Q

why is there a difference in the results of in vivo studies and clinical trials of bevacizumab

A

• established, slow growing tumours have different angiogenic requirements to fast growing tumours
o phase 3 patients had tumours for a while whereas mice have fast growing tumours
• dose choice: Use upper limiting dose (maybe its not the best dose)
• administration protocol – differences in 2 dosage schedule
• drugs have varied effects on different tumours
• assessed by effect on tumour shrinkage (RECIST)
• tumours out smart antiangiogenic therapy – multiple pro angiogenic factors. Multiple cross talk/cross regulation

76
Q

how does bevacizumab work

A

pruning of abnormal tumour vaculature
functional normalisation leads to reduced interstitial pressure
decrease in tumour hypoxia

77
Q

which cancers is bevacizumab approved for

A

metastatic colorectal cancer and lung cancer

78
Q

approval of bevacizumab was withdrawn for which cancer in 2011

A

breast cancer

79
Q

why was bavacizumab withdrawn for use in breast cancer

A

Increasing progression free survival but overall survival not increasing – end of life much more vigorous/damaging

80
Q

what is the aim of cancer treatment in patients with advanced disease

A
  • Improve quantity of life

* Improve quality of life

81
Q

Why does treatments that increase Progression Free Survival fail to improve Overall Survival

A
  • insufficient statistical power to detect significant difference
  • measurement of progression is imprecise whereas date of death is exact
  • biological effects
  • effect of post progression therapy
82
Q

• As the tumour endothelium is genetically stable it was predicted that resistance to antiangiogenic therapy would develop slowly. in fact,

A

it develops rapidly

83
Q

what are the 7 ways in which tumours can escape from treatment control

A
  1. hypoxia increases pro-angiogenic factor production
  2. vascular normalisation
  3. vascular mimicry
  4. expression of multiple angiogenic factors
  5. recruitment of bone marrow derived cells
  6. selection of metastatic cancer cells
  7. vessel co-option
84
Q

what is vascular normalisation

A

better blood flow into tumour so it can grow

85
Q

what is vascular mimicry

A

when vessels have been pruned, left with a channel. tumour cells mimic the blood vessels so still get blood flow where channel was

86
Q

what are bone marrow derived cells also known as and what can they do

A

endothelial progenitor cells. can form new cessels in a way that isnt angiogenesis

87
Q

selection for metastatic cancer cells is caused by cancer cells being stressed and therefore more likely to become…

A

metastatic

88
Q

what is vessel cooption

A

when tumour cells grow around cells that are already there

89
Q

one resistance mechanism to inhibiting VEGF is using an alternative signalling pathway for angiogenesis. what are the examples

A 
other VEGF isoforms
NRPs
PIGF
FGF
TGFbeta
integrins
90
Q

reduced tumour blood flow may lead to a more hostile tumour environment that promotes tumour invasion and metastasis T/F

A

T

91
Q

when there is increasing amounts of hypoxia the tumour looks like its getting inhibited so get increased progression free survival. but then what happens

A

get upregulation of alternative factors
tumour cells adapt to hypoxia
grows faster than it would have done if left alone

Biochem basis of human disease (6 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions